Wistar Institute: Synthetic DNA Technology Applied as a Novel Strategy for Delivery of Anti-HIV Antibodies
November 08, 2019
November 08, 2019
PHILADELPHIA, Pennsylvania, Nov. 8 -- The Wistar Institute issued the following news release:
Scientists at The Wistar Institute applied synthetic DNA-based technology to drive in vivo production of broadly neutralizing anti-HIV antibodies in small and large-animal models, providing proof of concept for a simple and effective next generation approach to HIV prevention and therapy. These results were published online in the Journal of Clinical Investigation.
Despite exc . . .
Scientists at The Wistar Institute applied synthetic DNA-based technology to drive in vivo production of broadly neutralizing anti-HIV antibodies in small and large-animal models, providing proof of concept for a simple and effective next generation approach to HIV prevention and therapy. These results were published online in the Journal of Clinical Investigation.
Despite exc . . .